| Predicate |
Object |
| contentType |
Journal Article|Research Support, N.I.H., Extramural |
| endingPage |
9 |
| issn |
0030-9982 |
| issueIdentifier |
1 |
| pageRange |
78-9 |
| publicationName |
JPMA. The Journal of the Pakistan Medical Association |
| startingPage |
78 |
| hasFundingAgency |
http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_95d40357f1e57287004d8282328df95b |
| isSupportedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_419fc2fb116d3af3459b5601456c0603 |
| bibliographicCitation |
Sidddiqi SA, Kamal AK. A new antiplatelet agent cilostazol--what is the evidence for its use and tolerability? J Pak Med Assoc. 2012 Jan;62(1):78–9. PMID: 22352114. |
| creator |
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_66b59e5d35c5890b292c4afc2266c3dd
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c751e35541ed8b285a5d26d4916df822 |
| date |
201201 |
| identifier |
https://pubmed.ncbi.nlm.nih.gov/22352114 |
| isPartOf |
http://rdf.ncbi.nlm.nih.gov/pubchem/journal/5350
https://portal.issn.org/resource/ISSN/0030-9982 |
| language |
English |
| source |
https://pubmed.ncbi.nlm.nih.gov/ |
| title |
A new antiplatelet agent cilostazol--what is the evidence for its use and tolerability? |
| discusses |
http://id.nlm.nih.gov/mesh/M0132637
http://id.nlm.nih.gov/mesh/M0017012
http://id.nlm.nih.gov/mesh/M0021253
http://id.nlm.nih.gov/mesh/M0001864 |
| hasPrimarySubjectTerm |
http://id.nlm.nih.gov/mesh/D013777Q000627
http://id.nlm.nih.gov/mesh/D020521Q000517
http://id.nlm.nih.gov/mesh/D013927Q000188
http://id.nlm.nih.gov/mesh/D010975Q000627 |
| hasSubjectTerm |
http://id.nlm.nih.gov/mesh/D001241Q000627
http://id.nlm.nih.gov/mesh/D019317
http://id.nlm.nih.gov/mesh/D000077407
http://id.nlm.nih.gov/mesh/D016032
http://id.nlm.nih.gov/mesh/D016896
http://id.nlm.nih.gov/mesh/D006801 |